FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18681211000001100: Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-May 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63981001000001116 Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63981101000001115 Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 2.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 2.5mg m/r tablet false Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has active ingredient Felodipine true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has specific active ingredient Felodipine true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Is a Neofel XL true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Is a Felodipine 2.5mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Neofel XL 2.5mg tablets (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start